MetLife Investment Management LLC Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD)

MetLife Investment Management LLC decreased its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 3.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,518 shares of the medical instruments supplier’s stock after selling 176 shares during the period. MetLife Investment Management LLC’s holdings in Mettler-Toledo International were worth $8,275,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. PineStone Asset Management Inc. lifted its position in shares of Mettler-Toledo International by 127.4% during the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after acquiring an additional 145,453 shares during the period. International Assets Investment Management LLC boosted its position in Mettler-Toledo International by 149,870.0% during the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after purchasing an additional 89,922 shares in the last quarter. Massachusetts Financial Services Co. MA grew its holdings in Mettler-Toledo International by 32.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock valued at $199,777,000 after purchasing an additional 35,048 shares during the last quarter. Swedbank AB acquired a new stake in Mettler-Toledo International in the first quarter valued at $26,867,000. Finally, Thrivent Financial for Lutherans raised its stake in shares of Mettler-Toledo International by 1,940.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 18,406 shares of the medical instruments supplier’s stock worth $27,604,000 after buying an additional 17,504 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of NYSE:MTD opened at $1,243.40 on Friday. The firm has a market capitalization of $26.24 billion, a PE ratio of 33.52, a P/E/G ratio of 4.10 and a beta of 1.16. Mettler-Toledo International Inc. has a 12 month low of $1,059.08 and a 12 month high of $1,546.93. The business has a 50-day moving average of $1,348.27 and a two-hundred day moving average of $1,395.43.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The firm had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. As a group, research analysts anticipate that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the sale, the director now directly owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.94% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts have weighed in on MTD shares. Stifel Nicolaus dropped their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Robert W. Baird cut their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Wells Fargo & Company lowered their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. JPMorgan Chase & Co. upped their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Finally, Evercore ISI increased their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $1,338.75.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.